Precision Biosciences

Filed a patent for "optimized engineered meganucleases having specificity for the human t cell receptor alpha constant region gene" on Thu, January 5, 2023

Filed a patent for "muscle-specific expression casettes" on Fri, April 14, 2023

Filed a patent for "muscle-specific expression cassettes" on Fri, April 14, 2023

Filed a patent for "muscle-specific expression cassettes" on Fri, May 19, 2023

Filed a patent for "muscle-specific expression cassettes" on Fri, May 19, 2023

Filed a patent for "polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene" on Thu, February 16, 2023

Filed a patent for "compositions and methods for sequential stacking of nucleic acid sequences into a genomic locus" on Thu, June 8, 2023

Filed a patent for "modified epidermal growth factor receptor peptides for use in genetically-modified cells" on Thu, June 8, 2023

Filed a patent for "self-limiting viral vectors encoding nucleases" on Thu, June 22, 2023

Filed a patent for "genetically-modified cells comprising a modified human t cell receptor alpha constant region gene" on Thu, January 4, 2024

Filed a patent for "engineered meganucleases that target human mitochondrial genomes" on Thu, September 21, 2023

Filed a patent for "rationally-designed single-chain meganucleases with non-palindromic recognition sequences" on Thu, December 28, 2023

Filed a patent for "lipid nanoparticle compositions" on Thu, November 16, 2023

Filed a patent for "engineered meganucleases having specificity for a recognition sequence in the hydroxyacid oxidase 1 gene" on Thu, September 12, 2024

Filed a patent for "polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene" on Thu, January 4, 2024

Filed a patent for "gene editing methods for treating alpha-1 antitrypsin (aat) deficiency" on Thu, April 18, 2024